XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Common Class A [Member]
Retained Earnings [Member]
Common Class B [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Common Class A [Member]
Parent [Member]
Common Class B [Member]
Parent [Member]
Noncontrolling Interest [Member]
Common Class A [Member]
Common Class B [Member]
Total
Balance (in shares) at Dec. 31, 2021 43,108,000 12,399,000                            
Balance at Dec. 31, 2021 $ 1,466,749   $ 563 $ 470,750 $ (36,933)     $ 1,031,582 $ 787     $ 1,466,749        
Stock options exercised and stock awards (in shares) 112,000                              
Stock options exercised and stock awards $ 2,385   1 2,384               2,385        
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       13,793               13,793        
Vesting of restricted share awards (in shares)   302,000                            
Vesting of restricted share awards $ (7,212)   3 (7,215)               (7,212)        
Issuance of common stock under employee stock purchase plan (in shares) 66,000                              
Issuance of common stock under employee stock purchase plan $ 2,435   1 2,434               2,435        
Common stock repurchases (in shares) (192,000) (104,000)                            
Common stock repurchases $ (15,315)       (15,315)             (15,315)        
Cash dividends declared           $ (8,189) $ (2,505)     $ (8,189) $ (2,505)          
Foreign currency translation adjustment                 445     445        
Net income               92,453       92,453        
Foreign currency translation                 445     445        
Balance (in shares) at Mar. 31, 2022 43,094,000 12,597,000                            
Balance at Mar. 31, 2022 $ 1,545,039   568 482,146 (52,248)     1,113,341 1,232     1,545,039        
Balance (in shares) at Dec. 31, 2021 43,108,000 12,399,000                            
Balance at Dec. 31, 2021 $ 1,466,749   563 470,750 (36,933)     1,031,582 787     1,466,749        
Foreign currency translation adjustment                               $ (122)
Net income                               203,126
Foreign currency translation                               (122)
Balance (in shares) at Jun. 30, 2022 42,808,000 12,266,000                            
Balance at Jun. 30, 2022     570 488,170 (90,686)     1,212,919 64     1,611,037 $ 18,274     1,629,311
Balance (in shares) at Mar. 31, 2022 43,094,000 12,597,000                            
Balance at Mar. 31, 2022 $ 1,545,039   568 482,146 (52,248)     1,113,341 1,232     1,545,039        
Stock options exercised and stock awards (in shares) 162,000                              
Stock options exercised and stock awards     2 3,244               3,246       3,246
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       4,203               4,203       4,203
Vesting of restricted share awards       (1,423)               (1,423)       (1,423)
Common stock repurchases (in shares) (448,000) (331,000)                            
Common stock repurchases         (38,438)             (38,438)       (38,438)
Cash dividends declared           (8,128) (2,521)     (8,128) (2,521)     $ (8,128) $ (2,521)  
Foreign currency translation adjustment                 (567)     (567)       (567)
Net income               110,227       110,227 446     110,673
Foreign currency translation                 (567)     (567)       (567)
Balance (in shares) at Jun. 30, 2022 42,808,000 12,266,000                            
Balance at Jun. 30, 2022     570 488,170 (90,686)     1,212,919 64     1,611,037 18,274     1,629,311
Reclassification of foreign currency translation related to equity method                 (601)     (601)       (601)
Noncontrolling interest equity                         17,828     17,828
Balance (in shares) at Dec. 31, 2022 42,345,000 12,083,000                            
Balance at Dec. 31, 2022     572 500,642 (130,930)     1,378,337 (4,130)     1,744,491       1,763,022
Stock options exercised and stock awards (in shares) 152                              
Stock options exercised and stock awards     2 3,412               3,414       3,414
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       13,080               13,080       13,080
Vesting of restricted share awards (in shares)   281,000                            
Vesting of restricted share awards     3 (6,964)               (6,961)       (6,961)
Issuance of common stock under employee stock purchase plan (in shares) 68,000                              
Issuance of common stock under employee stock purchase plan       2,828               2,828       2,828
Common stock repurchases (in shares) (415,000) (56,000)                            
Common stock repurchases         (25,280)             (25,280)       (25,280)
Cash dividends declared           (8,897) (2,692)     (8,897) (2,692)     (8,897) (2,692)  
Foreign currency translation adjustment                 232     232       232
Net income               90,455       90,455 335     90,790
Foreign currency translation                 232     232       232
Balance (in shares) at Mar. 31, 2023 42,150,000 12,308,000                            
Balance at Mar. 31, 2023     577 512,998 (156,210)     1,457,203 (3,898)     1,810,670 18,866     1,829,536
Balance (in shares) at Dec. 31, 2022 42,345,000 12,083,000                            
Balance at Dec. 31, 2022     572 500,642 (130,930)     1,378,337 (4,130)     1,744,491       1,763,022
Foreign currency translation adjustment                               1,921
Net income                               189,314
Foreign currency translation                               1,921
Balance (in shares) at Jun. 30, 2023 41,715,000 12,179,000                            
Balance at Jun. 30, 2023     578 522,375 (196,515)     1,543,941 (2,209)     1,868,170 19,115     1,887,285
Balance (in shares) at Mar. 31, 2023 42,150,000 12,308,000                            
Balance at Mar. 31, 2023     577 512,998 (156,210)     1,457,203 (3,898)     1,810,670 18,866     1,829,536
Stock options exercised and stock awards (in shares) 158,000                              
Stock options exercised and stock awards     1 3,479               3,480       3,480
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       5,952               5,952       5,952
Vesting of restricted share awards       (54)               (54)       (54)
Common stock repurchases (in shares) (593,000) (129,000)                            
Common stock repurchases         (40,305)             (40,305)       (40,305)
Cash dividends declared           $ (8,812) $ (2,725)     $ (8,812) $ (2,725)     $ (8,812) $ (2,725)  
Foreign currency translation adjustment                 1,689     1,689       1,689
Net income               98,275       98,275 249     98,524
Foreign currency translation                 1,689     1,689       1,689
Balance (in shares) at Jun. 30, 2023 41,715,000 12,179,000                            
Balance at Jun. 30, 2023     $ 578 $ 522,375 $ (196,515)     $ 1,543,941 $ (2,209)     $ 1,868,170 $ 19,115     $ 1,887,285